FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2128723975> ?p ?o ?g. }

• W2128723975 endingPage "1063" @default.
• W2128723975 startingPage "1059" @default.
• W2128723975 abstract "Objective: Angiogenesis represents a key element in the pathogenesis of malignancy. There are no robust data on prognostic factors for overall survival (OS) in patients with metastatic colorectal cancer treated with vascular endothelial growth factor (VEGF)-targeted therapy. The present study was conducted to establish a prognostic model for patients using an oxaliplatin-based or irinotecan-based chemotherapy plus bevacizumab in metastatic colorectal cancer. Methods: Baseline characteristics and outcomes on 170 patients treated with FOLFIRI or XELOX plus anti-VEGF therapy-naive metastatic colorectal cancer were collected from three Turkey cancer centers. Cox proportional hazards regression was used to identify independent prognostic factors for OS. Results: The median OS for the whole cohort was 19 months (95% CI, 14.3 to 23.6 months). Three of the seven adverse prognostic factors according to the Anatolian Society of Medical Oncology (ASMO) were independent predictors of short survival: serum lactate dehydrogenase (LDH) greater than the upper limit of normal (ULN; p<0.001); neutrophils greater than the ULN (p<0.0014); and progression free survival (PFS) less than 6 months (p =0.001). Conclusion: Serum LDH and neutrophil levels were the main prognostic factors in predicting survival, followed by PFS. This model validates incorporation of components of the ASMO model into patient care and clinical trials that use VEGF-targeting agents." @default.
• W2128723975 created "2016-06-24" @default.
• W2128723975 creator A5000554665 @default.
• W2128723975 creator A5002839209 @default.
• W2128723975 creator A5020545863 @default.
• W2128723975 creator A5033726162 @default.
• W2128723975 creator A5037670666 @default.
• W2128723975 creator A5044883162 @default.
• W2128723975 creator A5045696675 @default.
• W2128723975 creator A5064627647 @default.
• W2128723975 creator A5077193503 @default.
• W2128723975 date "2012-03-31" @default.
• W2128723975 modified "2023-10-17" @default.
• W2128723975 title "Prognostic Factors for Overall Survival in Patients With Metastatic Colorectal Carcinoma Treated With Vascular Endothelial Growth Factor-Targeting Agents" @default.
• W2128723975 cites W1539571840 @default.
• W2128723975 cites W1867387438 @default.
• W2128723975 cites W1979603074 @default.
• W2128723975 cites W1982530466 @default.
• W2128723975 cites W2010240290 @default.
• W2128723975 cites W2023385961 @default.
• W2128723975 cites W2027885836 @default.
• W2128723975 cites W2077129920 @default.
• W2128723975 cites W2099752220 @default.
• W2128723975 cites W2102347194 @default.
• W2128723975 cites W2109498035 @default.
• W2128723975 cites W2113092779 @default.
• W2128723975 cites W2120009106 @default.
• W2128723975 cites W2121368761 @default.
• W2128723975 cites W2133399075 @default.
• W2128723975 cites W2139806485 @default.
• W2128723975 cites W2140782074 @default.
• W2128723975 cites W2163899134 @default.
• W2128723975 cites W2166602936 @default.
• W2128723975 cites W2167422856 @default.
• W2128723975 cites W2169965478 @default.
• W2128723975 cites W2314927739 @default.
• W2128723975 doi "https://doi.org/10.7314/apjcp.2012.13.3.1059" @default.
• W2128723975 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22631638" @default.
• W2128723975 hasPublicationYear "2012" @default.
• W2128723975 type Work @default.
• W2128723975 sameAs 2128723975 @default.
• W2128723975 citedByCount "24" @default.
• W2128723975 countsByYear W21287239752013 @default.
• W2128723975 countsByYear W21287239752014 @default.
• W2128723975 countsByYear W21287239752015 @default.
• W2128723975 countsByYear W21287239752016 @default.
• W2128723975 countsByYear W21287239752018 @default.
• W2128723975 countsByYear W21287239752019 @default.
• W2128723975 countsByYear W21287239752020 @default.
• W2128723975 countsByYear W21287239752021 @default.
• W2128723975 countsByYear W21287239752022 @default.
• W2128723975 crossrefType "journal-article" @default.
• W2128723975 hasAuthorship W2128723975A5000554665 @default.
• W2128723975 hasAuthorship W2128723975A5002839209 @default.
• W2128723975 hasAuthorship W2128723975A5020545863 @default.
• W2128723975 hasAuthorship W2128723975A5033726162 @default.
• W2128723975 hasAuthorship W2128723975A5037670666 @default.
• W2128723975 hasAuthorship W2128723975A5044883162 @default.
• W2128723975 hasAuthorship W2128723975A5045696675 @default.
• W2128723975 hasAuthorship W2128723975A5064627647 @default.
• W2128723975 hasAuthorship W2128723975A5077193503 @default.
• W2128723975 hasBestOaLocation W21287239751 @default.
• W2128723975 hasConcept C121608353 @default.
• W2128723975 hasConcept C126322002 @default.
• W2128723975 hasConcept C143998085 @default.
• W2128723975 hasConcept C167734588 @default.
• W2128723975 hasConcept C181199279 @default.
• W2128723975 hasConcept C185592680 @default.
• W2128723975 hasConcept C2776694085 @default.
• W2128723975 hasConcept C2777025900 @default.
• W2128723975 hasConcept C2777318727 @default.
• W2128723975 hasConcept C2777802072 @default.
• W2128723975 hasConcept C2780259306 @default.
• W2128723975 hasConcept C2780394083 @default.
• W2128723975 hasConcept C2780962732 @default.
• W2128723975 hasConcept C50382708 @default.
• W2128723975 hasConcept C526805850 @default.
• W2128723975 hasConcept C55493867 @default.
• W2128723975 hasConcept C71924100 @default.
• W2128723975 hasConceptScore W2128723975C121608353 @default.
• W2128723975 hasConceptScore W2128723975C126322002 @default.
• W2128723975 hasConceptScore W2128723975C143998085 @default.
• W2128723975 hasConceptScore W2128723975C167734588 @default.
• W2128723975 hasConceptScore W2128723975C181199279 @default.
• W2128723975 hasConceptScore W2128723975C185592680 @default.
• W2128723975 hasConceptScore W2128723975C2776694085 @default.
• W2128723975 hasConceptScore W2128723975C2777025900 @default.
• W2128723975 hasConceptScore W2128723975C2777318727 @default.
• W2128723975 hasConceptScore W2128723975C2777802072 @default.
• W2128723975 hasConceptScore W2128723975C2780259306 @default.
• W2128723975 hasConceptScore W2128723975C2780394083 @default.
• W2128723975 hasConceptScore W2128723975C2780962732 @default.
• W2128723975 hasConceptScore W2128723975C50382708 @default.
• W2128723975 hasConceptScore W2128723975C526805850 @default.
• W2128723975 hasConceptScore W2128723975C55493867 @default.
• W2128723975 hasConceptScore W2128723975C71924100 @default.
• W2128723975 hasIssue "3" @default.
• W2128723975 hasLocation W21287239751 @default.

• next